According to Grifols's latest financial reports the company's current EPS (TTM) is $0.70. In 2020 the company made an earnings per share (EPS) of $1.05 an increase over its 2019 EPS that were of $1.02.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.70 | |
2020 | $1.05 | 2.92% |
2019 | $1.02 | -0.46% |
2018 | $1.02 | -8.46% |
2017 | $1.12 | 26.57% |
2016 | $0.88 | 3.68% |
2015 | $0.85 | -4.49% |
2014 | $0.89 | 31.92% |
2013 | $0.68 | 38.56% |
2012 | $0.49 | 273.37% |
2011 | $0.13 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 1,923.31% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 1,932.60% | ๐บ๐ธ USA |
Baxter BAX | $5.12 | 635.47% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $5.22 | 649.84% | ๐บ๐ธ USA |